These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 26225611)

  • 1. Survival time of dogs with splenic hemangiosarcoma treated by splenectomy with or without adjuvant chemotherapy: 208 cases (2001-2012).
    Wendelburg KM; Price LL; Burgess KE; Lyons JA; Lew FH; Berg J
    J Am Vet Med Assoc; 2015 Aug; 247(4):393-403. PubMed ID: 26225611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997-2004).
    Kim SE; Liptak JM; Gall TT; Monteith GJ; Woods JP
    J Am Vet Med Assoc; 2007 Nov; 231(10):1550-7. PubMed ID: 18021000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis for dogs with stage I or II splenic hemangiosarcoma treated by splenectomy alone: 32 cases (1991-1993).
    Wood CA; Moore AS; Gliatto JM; Ablin LA; Berg RJ; Rand WM
    J Am Anim Hosp Assoc; 1998; 34(5):417-21. PubMed ID: 9728473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant anthracycline-based vs metronomic chemotherapy vs no medical treatment for dogs with metastatic splenic hemangiosarcoma: A multi-institutional retrospective study of the Italian Society of Veterinary Oncology.
    Marconato L; Chalfon C; Finotello R; Polton G; Vasconi ME; Annoni M; Stefanello D; Mesto P; Capitani O; Agnoli C; Amati M; Sabattini S
    Vet Comp Oncol; 2019 Dec; 17(4):537-544. PubMed ID: 31251441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of clinical and histologic factors associated with survival time in dogs with stage II splenic hemangiosarcoma treated by splenectomy and adjuvant chemotherapy: 30 cases (2011-2014).
    Moore AS; Rassnick KM; Frimberger AE
    J Am Vet Med Assoc; 2017 Sep; 251(5):559-565. PubMed ID: 28828962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of outcome associated with subcutaneous and intramuscular hemangiosarcoma treated with adjuvant doxorubicin in dogs: 21 cases (2001-2006).
    Bulakowski EJ; Philibert JC; Siegel S; Clifford CA; Risbon R; Zivin K; Cronin KL
    J Am Vet Med Assoc; 2008 Jul; 233(1):122-8. PubMed ID: 18593321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timely adjuvant chemotherapy improves outcome in dogs with non-metastatic splenic hemangiosarcoma undergoing splenectomy.
    Faroni E; Sabattini S; Guerra D; Iannuzzi C; Chalfon C; Agnoli C; Stefanello D; Polton G; Ramos S; Aralla M; Ciaccini R; Foglia A; Okonji S; Marconato L
    Vet Comp Oncol; 2023 Mar; 21(1):123-130. PubMed ID: 36633399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does thalidomide prolong survival in dogs with splenic haemangiosarcoma?
    Bray JP; Orbell G; Cave N; Munday JS
    J Small Anim Pract; 2018 Feb; 59(2):85-91. PubMed ID: 29210452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The addition of metronomic chemotherapy does not improve outcome for canine splenic haemangiosarcoma.
    Alexander CK; Cronin KL; Silver M; Gardner HL; London C
    J Small Anim Pract; 2019 Jan; 60(1):32-37. PubMed ID: 30209807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma.
    Gardner HL; London CA; Portela RA; Nguyen S; Rosenberg MP; Klein MK; Clifford C; Thamm DH; Vail DM; Bergman P; Crawford-Jakubiak M; Henry C; Locke J; Garrett LD
    BMC Vet Res; 2015 Jun; 11():131. PubMed ID: 26062540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canine hemangiosarcoma treated with standard chemotherapy and minocycline.
    Sorenmo K; Duda L; Barber L; Cronin K; Sammarco C; Usborne A; Goldschmidt M; Shofer F
    J Vet Intern Med; 2000; 14(4):395-8. PubMed ID: 10935889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant Doxorubicin with or without Metronomic Cyclophosphamide for Canine Splenic Hemangiosarcoma.
    Matsuyama A; Poirier VJ; Mantovani F; Foster RA; Mutsaers AJ
    J Am Anim Hosp Assoc; 2017; 53(6):304-312. PubMed ID: 28892429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective comparison of first-line adjuvant anthracycline vs metronomic-based chemotherapy protocols in the treatment of stage I and II canine splenic haemangiosarcoma.
    Treggiari E; Borrego JF; Gramer I; Valenti P; Harper A; Finotello R; Toni C; Laomedonte P; Romanelli G
    Vet Comp Oncol; 2020 Mar; 18(1):43-51. PubMed ID: 31648405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous low-dose oral chemotherapy for adjuvant therapy of splenic hemangiosarcoma in dogs.
    Lana S; U'ren L; Plaza S; Elmslie R; Gustafson D; Morley P; Dow S
    J Vet Intern Med; 2007; 21(4):764-9. PubMed ID: 17708397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial.
    Vail DM; MacEwen EG; Kurzman ID; Dubielzig RR; Helfand SC; Kisseberth WC; London CA; Obradovich JE; Madewell BR; Rodriguez CO
    Clin Cancer Res; 1995 Oct; 1(10):1165-70. PubMed ID: 9815908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of 43 small breed dogs treated for splenic hemangiosarcoma.
    Story AL; Wavreille V; Abrams B; Egan A; Cray M; Selmic LE
    Vet Surg; 2020 Aug; 49(6):1154-1163. PubMed ID: 32562436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hemangiosarcoma in anemic dogs with a splenic mass and hemoperitoneum requiring a transfusion: 71 cases (2003-2005).
    Hammond TN; Pesillo-Crosby SA
    J Am Vet Med Assoc; 2008 Feb; 232(4):553-8. PubMed ID: 18279091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canine splenic haemangiosarcoma: influence of metastases, chemotherapy and growth pattern on post-splenectomy survival and expression of angiogenic factors.
    Göritz M; Müller K; Krastel D; Staudacher G; Schmidt P; Kühn M; Nickel R; Schoon HA
    J Comp Pathol; 2013 Jul; 149(1):30-9. PubMed ID: 23276383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma.
    U'Ren LW; Biller BJ; Elmslie RE; Thamm DH; Dow SW
    J Vet Intern Med; 2007; 21(1):113-20. PubMed ID: 17338158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canine visceral hemangiosarcoma treated with surgery alone or surgery and doxorubicin: 37 cases (2005-2014).
    Batschinski K; Nobre A; Vargas-Mendez E; Tedardi MV; Cirillo J; Cestari G; Ubukata R; Dagli MLZ
    Can Vet J; 2018 Sep; 59(9):967-972. PubMed ID: 30197439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.